Skip to main content

Morningside — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

113
Companies
$2.0B
Total invested
$25.2M
Avg. check
33
Industries
Biotechnology 13Health Care 12Therapeutics 5Medical 4Financial Services 3Medical Device 3+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 113
Breezeway
March 2026

Breezeway is a property care and services platform designed to reduce the headaches of property management.

Internet · BostonPrivate Equity
Medrhythms
March 2026

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Biotechnology · Boston$3.3M Series Unknown
Intellihealth
November 2025

Intellihealth develops medical technology software to diagnose obesity-related diseases.

Health Care · San Francisco$5.2M Series Unknown
Almond FinTech
November 2025

Almond uses routing orchestration to select optimal time, currency, and network for best possible cross-border payment rates.

Financial Services · BostonSeries Unknown
Ampa Health
October 2025

Ampa Health is a health technology business developing scalable brain stimulation technologies to treat depression, anxiety, and addiction.

Biotechnology · San Diego$8.5M Seed
Brook Health
October 2025

Brook is a remote patient monitoring and health coaching platform that helps people manage their chronic conditions

Apps · Seattle$28.0M Series B
Epigenic Therapeutics
September 2025

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Biotechnology · Shanghai$60.0M Series B
Cyted
August 2025

Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.

Artificial Intelligence (AI) · Cambridge$44.0M Series B
Zhishan Weixin Biotechnology
July 2025

Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases.

Biotechnology · ChengduSeries B
Suvera
May 2025

Support service for effective virtual long-term care

Apps · LondonNon Equity Assistance
Accro Bioscience
March 2025

Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.

Biotechnology · Suzhou$13.8M Series B
PhoreMost
September 2024

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Biopharma · Cambridge$12.0M Series B
CairnSurgical
August 2024

CairnSurgical is developing innovative patient-specific tools to guide surgical interventions for patients with cancer.

Health Care · Lebanon$4.5M Series A
Endolytix
August 2024

Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.

Biotechnology · Beverly$5.0M Debt Financing
DeepCure
April 2024

DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.

Artificial Intelligence (AI) · Boston$24.6M Series A
Kappa Pay
April 2024

Kappa offers the fastest, most affordable and reliable way for African businesses to pay their suppliers across the globe.

Financial Services · Boston$5.0M Seed
ASLAN Pharmaceuticals
March 2024

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Biotechnology · Singapore$5.0M Post Ipo Equity
OptoGlo
January 2024

OptoGlo is a product development company that pioneer in the use of nanotechnology to produce transparent ultra-high-definition displays.

Intellectual Property · Leominster$1.6M Series Unknown
Nasekomo
January 2024

Nasekomo is revolutionizing the human food chain by producing animal feeds from organic waste using bioconverting insects.

Agriculture · Sofia$8.8M Series A
Monument Bank
November 2023

Monument Bank is a bank focus on ‘mass affluent’ clients such as professionals, property investors, and entrepreneurs.

Financial Services · London$49.1M Series B
Yoga Llama
July 2023

Yoga Llama is an application for cell phones, making its usage easier for the customer.

Fitness · Sofia$1.1M Seed
VaxEquity
June 2023

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

Biotechnology · Cambridge$870K Grant
Vesigen Therapeutics
March 2023

Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.

Biotechnology · CambridgeGrant
Phage Pharm
March 2023

Phage Pharm is a professional enterprise in the industrialization of bacteriophages.

Biotechnology · Qingdao Shi$13.1M Series B

Where Morningside invests

Biotechnology13
Health Care12
Therapeutics5
Medical4
Financial Services3
Medical Device3

About Morningside's portfolio

How many companies has Morningside invested in?

Morningside has invested in 113 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Morningside invest in?

Morningside's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Financial Services. The firm invests across 33 different industry categories.

What is Morningside's largest investment?

Among tracked funding rounds, Epigenic Therapeutics received $60.0M in a Series B round. Morningside's total known invested capital is $2.0B.

What is the average investment size for Morningside?

Morningside's average investment size is $25.2M across its portfolio of 113 companies.

What are Morningside's most recent investments?

Recent Morningside portfolio additions include Breezeway, Medrhythms, Intellihealth, Almond FinTech, Ampa Health. These companies were founded in 2020 or later.

Reach the founders behind these 113 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →